%0 Journal Article
%T Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative.
%A Leshem YA
%A Chalmers JR
%A Apfelbacher C
%A Furue M
%A Gerbens LAA
%A Prinsen CAC
%A Schmitt J
%A Spuls PI
%A Thomas KS
%A Williams HC
%A Simpson EL
%A  
%J J Am Acad Dermatol
%V 82
%N 5
%D May 2020
%M 31926221
%F 15.487
%R 10.1016/j.jaad.2019.12.055
%X <B>BACKGROUND: </B>Measuring patient-centered outcomes in clinical practice is valuable for monitoring patients and advancing real-world research. A new initiative from the Harmonising Outcome Measures for Eczema (HOME) group aims to recommend what might be recorded for atopic eczema patients in routine clinical care.<BR><B>OBJECTIVE: </B>Prioritize outcome domains to measure atopic eczema in clinical practice and select valid and practical outcome measurement instruments for the highest-priority domain.<BR><B>METHODS: </B>An online survey of HOME members identified and ranked 21 possible health domains. Suitable instruments were then selected for the top-prioritized domain at the HOME VI meeting, using established consensus processes informed by systematic reviews of instrument quality.<BR><B>RESULTS: </B>Patient-reported symptoms was the top-prioritized domain. In accordance with psychometric properties and feasibility, there was consensus that the recommended instruments to measure atopic eczema symptoms in clinical practice are the POEM, the PO-SCORAD index, or both. The numeric rating scale for itch received support pending definition and validation in atopic eczema.<BR><B>CONCLUSIONS: </B>Following the first step of the HOME Clinical Practice initiative, we endorse using the POEM, the PO-SCORAD index, or both for measuring atopic eczema symptoms in clinical practice. Additional high-priority domains for clinical practice will be assessed at subsequent HOME meetings.